Yellow fever overview: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
Yellow fever is an acute viral disease often causing hemorrhagic illness in many African and South American countries. A vaccine exists to prevent disease onset and is wildly accessible in western countries and through aid-relief organizations.
Yellow fever is an acute [[Virus|viral]] disease.<ref name=Baron>{{cite book | author = Schmaljohn AL, McClain D.| title = Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). ''In: Baron's Medical Microbiology ''(Baron S ''et al'', eds.)| edition = 4th ed. | publisher = Univ of Texas Medical Branch|year = 1996|url = http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.2894| isbn= 0-9631172-1-1 }}</ref> It is an important cause of [[hemorrhage|hemorrhagic]] illness in many African and South American countries despite existence of an effective [[vaccine]]. The ''yellow'' refers to the [[jaundice]] symptoms that affect some patients.<ref name =WHO2000>{{cite web|url=http://www.who.int/csr/resources/publications/surveillance/WHO_Report_Infectious_Diseases.pdf |title=WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases |accessdate=2007-06-11|author=Anker M, Schaaf D, ''et al''|date= 2000-01-07| |format=PDF |publisher=WHO |pages=11 }}</ref>  
Yellow fever is an acute [[Virus|viral]] disease.<ref name=Baron>{{cite book | author = Schmaljohn AL, McClain D.| title = Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). ''In: Baron's Medical Microbiology ''(Baron S ''et al'', eds.)| edition = 4th ed. | publisher = Univ of Texas Medical Branch|year = 1996|url = http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mmed.section.2894| isbn= 0-9631172-1-1 }}</ref> It is an important cause of [[hemorrhage|hemorrhagic]] illness in many African and South American countries despite existence of an effective [[vaccine]]. The ''yellow'' refers to the [[jaundice]] symptoms that affect some patients.<ref name =WHO2000>{{cite web|url=http://www.who.int/csr/resources/publications/surveillance/WHO_Report_Infectious_Diseases.pdf |title=WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases |accessdate=2007-06-11|author=Anker M, Schaaf D, ''et al''|date= 2000-01-07| |format=PDF |publisher=WHO |pages=11 }}</ref>  
Yellow fever has been a source of several devastating [[epidemic]]s. French soldiers were attacked by yellow fever during the 1802 Haitian Revolution; more than half of the army perished due to the disease.<ref name=Bollet_2004>{{cite book | last = Bollet | first = AJ |  title = Plagues and Poxes: The Impact of Human History on Epidemic Disease | pages=pp. 48&ndash;9 | publisher = Demos Medical Publishing | year = 2004 | id = ISBN 188879979X }}</ref> Outbreaks followed by thousands of deaths occurred periodically in other Western Hemisphere locations until research, which included human volunteers (some of whom died), led to an understanding of the method of transmission to humans (primarily by mosquitos) and development of a vaccine and other preventative efforts in the early 20th century.
Yellow fever has been a source of several devastating [[epidemic]]s. French soldiers were attacked by yellow fever during the 1802 Haitian Revolution; more than half of the army perished due to the disease.<ref name=Bollet_2004>{{cite book | last = Bollet | first = AJ |  title = Plagues and Poxes: The Impact of Human History on Epidemic Disease | pages=pp. 48&ndash;9 | publisher = Demos Medical Publishing | year = 2004 | id = ISBN 188879979X }}</ref> Outbreaks followed by thousands of deaths occurred periodically in other Western Hemisphere locations until research, which included human volunteers (some of whom died), led to an understanding of the method of transmission to humans (primarily by mosquitos) and development of a vaccine and other preventative efforts in the early 20th century.

Revision as of 18:12, 7 December 2012

Yellow fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Yellow Fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Future or Investigational Therapies

Treatment

Case #1

Yellow fever overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Yellow fever overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Yellow fever overview

CDC on Yellow fever overview

Yellow fever overview in the news

Blogs on Yellow fever overview

Directions to Hospitals Treating Yellow fever

Risk calculators and risk factors for Yellow fever overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Yellow fever is an acute viral disease.[1] It is an important cause of hemorrhagic illness in many African and South American countries despite existence of an effective vaccine. The yellow refers to the jaundice symptoms that affect some patients.[2] Yellow fever has been a source of several devastating epidemics. French soldiers were attacked by yellow fever during the 1802 Haitian Revolution; more than half of the army perished due to the disease.[3] Outbreaks followed by thousands of deaths occurred periodically in other Western Hemisphere locations until research, which included human volunteers (some of whom died), led to an understanding of the method of transmission to humans (primarily by mosquitos) and development of a vaccine and other preventative efforts in the early 20th century. Despite the costly and sacrificial breakthrough research by Cuban physician Carlos Finlay, American physician Walter Reed, and many others over 100 years ago, unvaccinated populations in many developing nations in Africa and Central and South America continue to be at risk.[4] As of 2001, the World Health Organization (WHO) estimates that yellow fever causes 200,000 illnesses and 30,000 deaths every year in unvaccinated populations.[5]

References

  1. Schmaljohn AL, McClain D. (1996). Alphaviruses (Togaviridae) and Flaviviruses (Flaviviridae). In: Baron's Medical Microbiology (Baron S et al, eds.) (4th ed. ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1.
  2. Anker M, Schaaf D; et al. (2000-01-07). "WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases" (PDF). WHO. p. 11. Retrieved 2007-06-11.
  3. Bollet, AJ (2004). Plagues and Poxes: The Impact of Human History on Epidemic Disease. Demos Medical Publishing. pp. pp. 48&ndash, 9. ISBN 188879979X.
  4. Tomori O (2002). "Yellow fever in Africa: public health impact and prospects for control in the 21st century". Biomedica. 22 (2): 178–210. PMID 12152484.
  5. "Yellow fever fact sheet". WHO—Yellow fever. Retrieved 2006-04-18.


Template:WikiDoc Sources